mushroom

Twist Bioscience Now Shipping Synthetic RNA Positive Controls for Delta (B.1.617.2) SARS-CoV-2 Variant for Development of Accurate Diagnostic Tests

COVID-19

Home » Health and medicine » COVID-19

mushroom

Amyris Completes First Major License For Leading RNA Vaccine Advancing Technology To Human Trials

EMERYVILLE, Calif., July 1, 2021 /PRNewswire/ — Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier...

mushroom

Duke-NUS and GenScript Announce Notice of Allowance for U.S. Patent Application for SARS-CoV-2 Surrogate Virus Neutralization Test

Sherlock Biosciences’ 221b Foundation Enables Global Access to COVID-19 Diagnostics with Up To 10 Million Tests Per Month

Multiple Partnerships Ensure Point-of-care and High-throughput CRISPR COVID-19 Diagnostic Kits at Global Scale June 23, 2021 08:30 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–The 221b Foundation, a...

mushroom

Anna Biosciences Launches Pioneering Immunotherapeutic Treatment to Fight COVID-19

mushroom

The 221b Foundation Grants License to ALBOT Technologies to Develop, Manufacture and Distribute CRISPR COVID-19 Diagnostic Kits in India

mushroom

Sherlock Biosciences Announces Initial Results of Automation Study with NorDx Laboratories on CRISPR-based Test for SARS-CoV-2

mushroom

Ginkgo Bioworks Teams with Quest Diagnostics to Provide COVID-19 Testing for K-12 Schools Nationwide

mushroom

Helix Announces Partnership with Ginkgo Bioworks to Support Back to School COVID-19 Testing Across the Western U.S.

mushroom

Olive Labs Inc. Announces Partnership with Ginkgo Bioworks to Scale COVID Response through Pooled Testing in K-12 Schools

concentric

Dascena Labs Announces Partnership with Concentric by Ginkgo to Scale COVID Response through K-12 Classroom Testing

mushroom

Twist Bioscience and Biotia Receive U.S. FDA Emergency Use Authorization for First Hybridization Capture-Based Next-Generation Sequencing SARS-CoV-2 Assay

mushroom

Twist Bioscience Begins Shipping of Synthetic RNA Controls for B.1.351 and P.1 Variants

mushroom

Codex DNA Releases World’s First Synthetic Genomes for Emerging SARS-CoV-2 Variants

mushroom

Amyris Announces Positive Pre-Clinical Results For COVID-19 RNA Vaccine Platform With Advantaged Manufacturing, Storage And Distribution Characteristics

mushroom

Ginkgo Bioworks Selected to Provide Pooled COVID-19 Testing for Massachusetts K-12 Schools